Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
APGE holding history
Apogee Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APGE overviewAll 13F holders of APGEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −9,000−100.0% | Sold out | Holders |
| Q1 2026 | 9,000 | $757.5K | 0.4% | −7,000−43.8% | Reduced | Holders |
| Q4 2025 | 16,000 | $1.21M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2025 | 16,000 | $635.7K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 16,000 | $694.9K | 0.7% | +8,000+100.0% | Added | Holders |
| Q1 2025 | 8,000 | $298.9K | 0.3% | +8,000 | New | Holders |